Comparison of Effectiveness of Detrusor, Suburothelial and Bladder Base Injections of Botulinum Toxin A for Idiopathic Detrusor Overactivity

Journal of Urology

Volumn 178, Issue 4, 2007, Pages 1359-1363

  Kuo, Hann Chorng ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

botulinum toxin type A; overactive; urinary bladder; urodynamics

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTALGIA; CYSTOMETRY; DETRUSOR DYSSYNERGIA; DISEASE SEVERITY; DYSURIA; FEMALE; HEMATURIA; HUMAN; IDIOPATHIC DISEASE; INFORMATION PROCESSING; INJECTION SITE; MALE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; RESIDUAL URINE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; URETHRAL PAIN; URINARY TRACT INFECTION; URINARY URGENCY; URINE INCONTINENCE; URINE RETENTION; URODYNAMICS; VESICOURETERAL REFLUX; VIDEORECORDING;

AGED; BOTULINUM TOXIN TYPE A; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URODYNAMICS; UROGRAPHY; UROTHELIUM;

EID: 34548455967     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.05.136     Document Type: Article

References (18)

1. Reitz A., Stohrer M., Kramer G., DelPopolo G., Chartier-Kastler E., Pannek J., et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45 (2004) 510
2. Kuo H.C. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 63 (2004) 868
3. Simpson L.L. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 212 (1980) 16
4. Popat R., Apostolidis A., Kalsi V., Gonzales G., Fowler C.J., and Dasgupta P. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 174 (2005) 984
5. Kessler T.M., Danuser H., Schumacher M., Studer V.E., and Burkhard F.C. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?. Neurourol Urodyn 24 (2005) 231
6. Apostolidis A., Popat R., Yiangou Y., Cockayne D., Ford A.P., Davis J.B., et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174 (2005) 977
7. Schulte-Baukloh H., Weiss C., Stolze T., Sturzebecher B., and Knispel H.H. Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 66 (2005) 82
8. Kuo H.C. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics. Urology 66 (2005) 94
9. Yiangou Y., Facer P., Ford A., Brady C., Wiseman O., Fowler C.J., et al. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int 87 (2001) 774
10. Powell D.W., Mifflin R.C., Valentich J.D., Crowe S.E., Saada J.I., and West A.B. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 277 (1999) C183
11. Yucel S., and Baskin L.S. An anatomical description of the male and female urethral sphincter complex. J Urol 171 (2004) 1890
12. Klein L.A. Urge incontinence can be a disease of bladder sensors. J Urol 139 (1988) 1010
13. McInerney P.D., Vanner T.F., Matenhelia S., and Stephenson T.P. Assessment of the long-term results of subtrigonal phenolisation. Br J Urol 67 (1991) 586
14. Westney O.L., Lee J.T., McGuire E.J., Palmer J.L., Cespedes R.D., and Amundsen C.L. Long-term results of Ingelman-Sundberg denervation procedure for urge incontinence refractory to medical therapy. J Urol 168 (2002) 1044
15. Cockayne D.A., Hamilton S.G., Zhu Q.M., Dunn P.M., Zhong Y., Novakovic S., et al. Urinary bladder hyporeflexia and reduced pain-related behavior in P2X3-deficient mice. Nature 407 (2000) 1011
16. Kuo H.C. Will suburothelial injection of a small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?. Urology 68 (2006) 993
17. Boy S., Schmid M., Reitz A., VonHessling A., Hodler J., and Schurch B. Botulinum toxin injections into the bladder wall - a morphological evaluation of the injection technique using magnetic resonance imaging. J Urol 175 suppl. (2006) 415 abstract 1287
18. Karsenty G., Elzayat E., Delapparent T., St-Denis B., Lemieux M.C., and Corcos J. Botulinum toxin type A injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. J Urol 177 (2007) 1011